CINECA IRIS Institutional Research Information System

Monoclonal antibodies for the treatment of non-haematological tumours: Update of an expanding scenario

PASSIGLIA, Francesco;
2015-01-01
2015
15
1
45
59
Cancer; Cancer antigen; Cytotoxic T-lymphocyte antigen 4; EGFR; HER2; Immunotherapy; MoAbs; Receptor activator of nuclear factor κB ligand; VEGF; Antibodies; Monoclonal; Drug Approval; Drug Discovery; Humans; Immunotherapy; Neoplasms; United States; United States Food and Drug Administration; Pharmacology; Clinical Biochemistry; Drug Discovery3003 Pharmaceutical Science; Medicine (all); Cancer; Cancer antigen; Cytotoxic T-lymphocyte antigen 4; EGFR; HER2; Immunotherapy; MoAbs; Receptor activator of nuclear factor κB ligand; VEGF; Antibodies; Monoclonal; Drug Approval; Drug Discovery; Humans; Immunotherapy; Neoplasms; United States; United States Food and Drug Administration; Pharmacology; Clinical Biochemistry; Drug Discovery3003 Pharmaceutical Science; Medicine (all)
BRONTE, Giuseppe; SORTINO, Giovanni; PASSIGLIA, Francesco; RIZZO, Sergio; LO VULLO, Francesca; GALVANO, Antonio; BAZAN, Viviana; Rolfo, Christian Diego; RUSSO, Antonio
File in questo prodotto:
File Dimensione Formato  
Monoclonal antibodies for the treatment of non haematological tumours update of an expanding scenario.pdf

Accesso riservato

Tipo di file: PDF EDITORIALE
Dimensione 554.33 kB
Formato Adobe PDF
  Visualizza/Apri   Richiedi una copia
554.33 kB Adobe PDF   Visualizza/Apri   Richiedi una copia

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/2318/1692397
Citazioni
  • ???jsp.display-item.citation.pmc??? 4
  • Scopus 7
  • ???jsp.display-item.citation.isi??? 6
social impact